Table I.
Association of lncRNA PEG10 expression with clinicopathological characteristics.
| Clinicopathological characteristics | n | lncRNA PEG10 expression (2−ΔΔCq values)a | P-value |
|---|---|---|---|
| Patient number | 56 | ||
| Age, years | 0.3580 | ||
| ≤60 | 32 | 3.2725±1.2293 | |
| >60 | 24 | 3.5850±1.2734 | |
| Sex | 0.1219 | ||
| Male | 40 | 3.2430±1.2221 | |
| Female | 16 | 3.8150±1.2514 | |
| Primary tumor site | 0.9938 | ||
| Pyriform sinuses | 39 | 3.3967±1.3083 | |
| Posterior and lateral hypo-pharyngeal walls | 13 | 3.4169±1.1604 | |
| Postcricoid area | 4 | 3.4675±1.1915 | |
| Pathological differentiation | 0.4564 | ||
| Well-differentiated | 12 | 3.0208±1.1527 | |
| Moderately differentiated | 19 | 3.5931±1.1285 | |
| Poorly differentiated | 25 | 3.4496±1.3761 | |
| Primary tumor size | 0.0174 | ||
| T1 | 13 | 2.8131±1.0142 | |
| T2 | 23 | 3.2330±1.1519 | |
| T3 | 20 | 3.9915±1.2943 | |
| Lymph node status | 0.0002 | ||
| N0 | 19 | 2.5774±0.9506 | |
| N+ | 37 | 3.8322±1.1720 | |
| Clinical staging (Tumor node metastasis) | <0.0000 | ||
| I/II | 13 | 2.2100±0.7106 | |
| III | 15 | 3.2920±0.7290 | |
| IV | 28 | 4.0232±1.2550 |
a
Data are presented as the mean ± standard deviation.